In the last several years, the development of an effective breast cancer screening procedure has increased the possibility of the early detection of this cancer.
We investigated the cost-effectiveness of a breast cancer screening program to screen 100,000 women 50-64 years of age in Catalonia (Spain).
The cost-effectiveness ratio was measured in terms of the cost per cancer detected comparing program costs to the estimated number of cancers detected.
We assumed a participation rate, sensitivity, and specificity of 70%, 92%, and 94%, respectively, and that 0.36 breast cancers could be detected per 100 women screened.
We estimated a total cost of $2.1 million with $1.4 million for the mammographic stage and $0.7 million for the detection of the true positive mammographic results.
The cost per woman screened was $30.
We estimated that 252 cases of breast cancer could be detected with the program.
The cost-effectiveness ratio obtained in this study was $8,424 per cancer detected.
Sensitivity analysis has shown that cost-effectiveness results are sensitive to the variations in the following variables : specificity, cancer detection rate, and screening costs.
In planning preventive programs, breast cancer screening should be considered one of the priorities.
Mots-clés Pascal : Tumeur maligne, Glande mammaire, Dépistage, Analyse coût efficacité, Economie santé, Programme sanitaire, Evaluation, Femme, Homme, Espagne, Europe, Prévention, Mammographie, Radiodiagnostic, Glande mammaire pathologie
Mots-clés Pascal anglais : Malignant tumor, Mammary gland, Medical screening, Cost efficiency analysis, Health economy, Sanitary program, Evaluation, Woman, Human, Spain, Europe, Prevention, Mammography, Radiodiagnosis, Mammary gland diseases
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 96-0240095
Code Inist : 002B20E01. Création : 199608.